Entry characteristics of children who completed the trial
| Placebo group (n=26) | Treatment group (n=24) | |
|---|---|---|
| Values are number (%) or mean (SD). | ||
| *p<0.05 (t test). | ||
| †Reported eczema or rhinitis excluding wheeze or “asthma” as a diagnosis. | ||
| M/F | 16/10 | 13/11 |
| Age (months) | 35.6 (8.5) | 36.2 (10.0) |
| Recalled symptoms in previous winter | ||
| No of episodes | 3.5 (1.8) | 4.2 (6.3) |
| Episode duration (days) | 8.6 (6.0) | 12.1 (6.3)* |
| Symptoms between episodes | ||
| Days per month | 5.0 (4.2) | 6.2 (4.8) |
| Nights per month | 8.3 (5.1) | 9.1 (4.1) |
| Personal atopy† | 9 (35%) | 5 (21%) |
| Parental asthma | 14 (54%) | 13 (54%) |
| Maternal smoking | 7 (27%) | 9 (38%) |